M42 is introducing AI-driven diagnostic tools for prostate cancer in the UAE. This initiative aims to enhance the early detection and diagnosis of prostate cancer within the region's healthcare system. The technology leverages artificial intelligence to improve the accuracy and efficiency of diagnostic processes. Why it matters: This development marks a significant advancement in the application of AI within the Middle East's healthcare sector, potentially leading to improved patient outcomes and fostering the adoption of cutting-edge medical technologies in the UAE.
An AI tool has reportedly been developed that can detect pancreatic cancer up to three years before a clinical diagnosis. This finding, based on a new study, was highlighted in a report by The National. The tool aims to significantly improve early detection capabilities for a challenging disease. Why it matters: Early and accurate detection of pancreatic cancer could lead to earlier interventions and substantially improve patient outcomes and survival rates.
Based on the title, UAE researchers are exploring the application of artificial intelligence for the early detection of Alzheimer's disease. The research aims to identify the condition up to 20 years prior to the typical onset of symptoms, representing a significant advancement if achieved. This initiative underscores the UAE's strategic commitment to leveraging AI for major breakthroughs in healthcare. Why it matters: Such a breakthrough in ultra-early Alzheimer's detection could revolutionize preventative care and treatment strategies globally, offering an unprecedented window for intervention and disease management.
Researchers introduce TomFormer, a transformer-based model for accurate and early detection of tomato leaf diseases, with the goal of deployment on the Hello Stretch robot for real-time diagnosis. TomFormer combines a visual transformer and CNN, achieving state-of-the-art results on KUTomaDATA, PlantDoc, and PlantVillage datasets. KUTomaDATA was collected from a greenhouse in Abu Dhabi, UAE.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
MBZUAI's Dr. Mohammad Yaqub is developing AI algorithms to power point-of-care ultrasound (PoCUS) on mobile devices, expanding on his prior work on an AI-based fetal anomaly system used in GE Healthcare's ultrasound. These algorithms aim to make smaller, affordable PoCUS devices accessible in remote areas for faster diagnoses. The handheld devices, costing around $5000 USD, can connect to mobile devices and provide intelligence to interpret images, addressing the shortage of specialists in remote locations. Why it matters: This initiative democratizes access to critical diagnostic tools, potentially saving lives by enabling early detection of life-threatening conditions in underserved communities.
UAE universities, including Khalifa University and Gulf Medical University, are actively leveraging AI tools for cancer research and early detection efforts. Researchers at Khalifa University are developing AI models to enhance early diagnosis and predict treatment responses across various cancers like breast, brain, lung, and prostate. Gulf Medical University also employs AI and machine learning in its research initiatives related to cancer treatment and diagnosis. Why it matters: These initiatives highlight the UAE's commitment to advancing healthcare through artificial intelligence, contributing to global efforts in disease combat and aligning with broader health equity goals.
KAUST and the National Center for Wildlife (NCW) are collaborating on research to protect Saudi Arabia's coastal ecosystems and marine economy from invasive species. They are conducting biodiversity surveys along the Red Sea and Arabian Gulf coasts, having surveyed 34 sites and collected over 10,000 samples. So far, 200 species with potential marine invasive traits have been identified, expanding the national knowledge base of marine life. Why it matters: The partnership aims to develop early detection and monitoring systems, fortifying Saudi Arabia's marine biosecurity efforts and supporting its Vision 2030 blue economy goals.